Navigation Links
Intradyn TearAway

ProductsIntradyn TearAway
Company B. Braun Medical Inc.
Item Intradyn TearAway
Features SpinLock assembly holds the dilator and sheath together to prevent the dilator from backing out of the sheath during insertion. PreScored Tearing Line ensures a clean, even tear, simplifying sheath removal after lead/catheter placement. Kink resistant FEP material assures sheath integrity and enhances smoothness of device insertion. Smooth dilator taper and dilator-sheath transition facilitates atraumatic entry of device into the vasculature. 18 gauge needle, 10mL syringe included.
Description The Intradyn Tear-Away Introducer Sheath with Spin-Lock offers a secure dilatorsheath connection, a smooth dilatorsheath transition and a clean, even tear.
Info B. Braun Medical Inc.
Customer Service: (610) 691-5400
Web site: http://www.bbraunusa.com

Related medicine products :

1. FLEXOR CHECK-FLO INTRODUCER SETS SMALL VALVE ASSEMBLY
2. FLEXOR Introducers BALKIN Up & Over Contralateral Design with Radiopaque Band
3. FLEXOR CHECK-FLO Introducer RAABE Modification with Radiopaque Band
4. SHUTTLE-SL FLEXOR TUOHY-BORST Side-Arm Introducer Sets
5. FLEXOR CHECK-FLO Introducer Set Large Valve Assembly with Radiopaque Band
6. FLEXOR CHECK-FLO Introducer Sets Small Valve Assembly
7. FLEXOR CHECK-FLO Introducer Set Large Valve Assembly with Radio-opaque Band
8. FLEXOR CHECK-FLO Introducer Sets for Radial Artery Access with AQ Hydrophylic Coating
9. Fast-Cath & Maximum Hemostasis Introducers
10. Ultimum Introducers
11. Fast-Cath Hemostasis Introducers
Other Medicine News:Health News:MedQuist and Clario Form Partnership to Integrate zVision Radiology Practice Management Software with SpeechQ for Radiology 2Health News:MedQuist and Clario Form Partnership to Integrate zVision Radiology Practice Management Software with SpeechQ for Radiology 3Health News:Turn the Corner Honors Andy Abrahams Wilson, Director of Under Our Skin, for His Dedication in the Fight Against Lyme Disease 2Health News:Turn the Corner Honors Andy Abrahams Wilson, Director of Under Our Skin, for His Dedication in the Fight Against Lyme Disease 3Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 3Health News:Natural Nutrition Canadian Subsidiary Signs $50.5 Million (CDN) Five Year European Distribution Contract 2Health News:KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q 2Health News:KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q 3Health News:KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q 4Health News:Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues. 2Health News:Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues. 3
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Sex based prenatal brain differences found 10503 1Sex based prenatal brain differences found 10503 2Bladder Problems May Often Be Related to Mental Health 59989 1Bladder Problems May Often Be Related to Mental Health 59989 2Why antidepressants dont work for so many 59985 1Why antidepressants dont work for so many 59985 2Why antidepressants dont work for so many 59985 3